专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US09490228B2 Anisotropic conductive film including conductive adhesive layer and semiconductor device connected by the same 有权
标题翻译：各向异性导电膜包括导电粘合剂层和与其相连的半导体器件
公开(公告)号：US09490228B2
公开(公告)日：2016-11-08
申请号：US14229003
申请日：2014-03-28
申请人： Kyoung Soo Park , Soon Young Kwon , Ji Yeon Kim , Young Woo Park , Jae Sun Han , Ja Young Hwang
发明人： Kyoung Soo Park , Soon Young Kwon , Ji Yeon Kim , Young Woo Park , Jae Sun Han , Ja Young Hwang
IPC分类号： H01L23/00 , C09J9/02 , C09J7/00 , C09J11/00 , H05K3/32 , C08K7/16 , C08K9/02
CPC分类号： H01L24/29 , C08K7/16 , C08K9/02 , C09J7/00 , C09J7/10 , C09J9/02 , C09J11/00 , C09J2201/36 , C09J2201/602 , C09J2203/326 , C09J2205/102 , H01L24/13 , H01L24/16 , H01L24/27 , H01L24/32 , H01L24/81 , H01L24/83 , H01L2224/13013 , H01L2224/16225 , H01L2224/27003 , H01L2224/271 , H01L2224/29082 , H01L2224/29083 , H01L2224/2919 , H01L2224/2929 , H01L2224/29311 , H01L2224/29316 , H01L2224/29324 , H01L2224/29339 , H01L2224/29344 , H01L2224/29347 , H01L2224/29355 , H01L2224/29364 , H01L2224/29366 , H01L2224/29371 , H01L2224/29387 , H01L2224/2939 , H01L2224/29411 , H01L2224/29416 , H01L2224/29424 , H01L2224/29439 , H01L2224/29444 , H01L2224/29447 , H01L2224/29455 , H01L2224/29464 , H01L2224/29466 , H01L2224/29471 , H01L2224/29499 , H01L2224/32225 , H01L2224/81191 , H01L2224/81903 , H01L2224/83192 , H01L2224/83203 , H01L2224/83851 , H01L2924/07802 , H01L2924/15788 , H05K3/323 , Y10T428/24959 , Y10T428/25 , Y10T428/28 , Y10T428/2848 , H01L2924/00 , H01L2924/00014 , H01L2924/00012
摘要： An anisotropic conductive film includes a conductive adhesive layer including conductive particles and insulating particles, and an insulating adhesive layer not including conductive particles. In the anisotropic conductive film, the conductive particles and the insulating particles of the conductive adhesive layer have a total particle density of 7.0×105/d2 to 10.0×105/d2 (particles) per square millimeter (mm2) (where d is a diameter of the conductive particles in μm).
摘要翻译：各向异性导电膜包括导电性粘合剂层，其包含导电性粒子和绝缘性粒子，以及不含导电性粒子的绝缘性粘合剂层。在各向异性导电膜中，导电性粘接剂层的导电性粒子和绝缘性粒子的总粒子密度为7.0×10 5 / d 2〜10 10×10 6（粒子）/平方毫米（mm 2）（d为直径的导电粒子）。

12. 发明授权

US09359592B2 Method for differentiation into retinal cells from stem cells 有权
标题翻译：从干细胞分化成视网膜细胞的方法
公开(公告)号：US09359592B2
公开(公告)日：2016-06-07
申请号：US13055709
申请日：2010-10-06
申请人： Sung Sup Park , Ji Yeon Kim
发明人： Sung Sup Park , Ji Yeon Kim
IPC分类号： C12N5/07 , A61P27/02 , C12Q1/02 , A61K35/44 , C12N5/079
CPC分类号： C12N5/0621 , C12N2501/105 , C12N2501/155 , C12N2501/998 , C12N2506/02 , C12N2506/45
摘要： Disclosed is a method for inducing stem cells to differentiate into retinal cells at high yield within a short period of time, without gene implantation and co-culture with retinal tissues, by implementing a differentiation process similar to the in vivo embryonic development in chemically defined conditions. Also, retinal cells including the photoreceptor cells and their progenitor cells, and various types of other retinal cells, generated according to the method, are disclosed. A composition comprising the retinal cells and a method are provided for treating retinal degeneration-related diseases. The differentiated photoreceptor cells, when transplanted into degenerated or injured retinas, can be engrafted and fused within the retinas to prevent or cure retinal degeneration.
摘要翻译：公开了一种诱导干细胞在短时间内以高产率分化成视网膜细胞的方法，通过实施类似于在化学定义的条件下的体内胚胎发育的分化过程，而不进行基因植入和与视网膜组织的共培养。此外，还公开了根据该方法产生的包括感光细胞及其祖细胞的视网膜细胞和各种类型的其它视网膜细胞。提供了包含视网膜细胞的组合物和一种治疗视网膜变性相关疾病的方法。分化的感光细胞，当移植到退化或损伤的视网膜时，可以植入并融合在视网膜内，以预防或治愈视网膜变性。

13. 发明授权

US09200252B2 Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising Wnt signaling pathway activators 有权
标题翻译：用于诱导从视网膜祖细胞分化成视网膜细胞或诱导包含Wnt信号通路激活剂的视网膜细胞增殖的组合物
公开(公告)号：US09200252B2
公开(公告)日：2015-12-01
申请号：US13055708
申请日：2010-10-06
申请人： Sung Sup Park , Ji Yeon Kim
发明人： Sung Sup Park , Ji Yeon Kim
IPC分类号： C12N5/071 , C12N5/07 , C12N5/0793 , A61K35/12
CPC分类号： C12N5/062 , A61K35/12 , C12N2500/44 , C12N2501/105 , C12N2501/115 , C12N2501/155 , C12N2501/385 , C12N2501/41 , C12N2501/415 , C12N2506/02 , C12N2506/45
摘要： Disclosed is a composition for inducing the proliferation of retinal cells or the differentiation of retinal progenitor cells into retinal cells. The composition, similar to in vivo conditions for development during embryogenesis, induces stem cells to differentiate into a multitude of photoreceptor cells at high yield within a short period of time, without an additional gene transfer. In addition, the differentiated photoreceptor cells are useful in cellular therapy because they, when transplanted into degenerated or injured retinas, can be engrafted and fused within the retinas to prevent or cure retinal degeneration.
摘要翻译：公开了用于诱导视网膜细胞增殖或将视网膜祖细胞分化成视网膜细胞的组合物。与胚胎发生期间的体内发育条件类似的组合物诱导干细胞在短时间内以高产率分化成多种感光细胞细胞，而不需要额外的基因转移。此外，分化的感光细胞可用于细胞治疗，因为它们在移植到退化或损伤的视网膜中时可以被植入并融合在视网膜内以预防或治愈视网膜变性。

14. 发明申请

US20140206616A1 Sustained-Release Lipid Pre-Concentrate of Pharmacologically Active Substance And Pharmaceutical Composition Comprising The Same 有权
标题翻译：药物活性物质和药物组合物的缓释脂质浓缩物
公开(公告)号：US20140206616A1
公开(公告)日：2014-07-24
申请号：US14241696
申请日：2012-08-28
申请人： Jin Young Ko , Ji Yeon Kim , So Hyun Park , Sung Won An , Min Hyo Ki
发明人： Jin Young Ko , Ji Yeon Kim , So Hyun Park , Sung Won An , Min Hyo Ki
IPC分类号： A61K47/22 , A61K47/14 , A61K47/10 , A61K31/18 , A61K47/24 , A61K31/713 , A61K38/26
CPC分类号： A61K47/22 , A61K9/0019 , A61K9/0024 , A61K9/1075 , A61K31/18 , A61K31/58 , A61K31/713 , A61K38/26 , A61K47/10 , A61K47/14 , A61K47/24 , A61K47/26 , A61K48/0016
摘要： Disclosed is a sustained release lipid pre-concentrate, comprising: a) a sorbitan unsaturated fatty acid ester having a polar head with at least two or more —OH (hydroxyl) groups; b) a phospholipid; and c) a liquid crystal hardener, free of an ionizable group, having a hydrophobic moiety of 15 to 40 carbon atoms with a triacyl group or a carbon ring structure. The lipid pre-concentrate exists as a liquid phase in the absence of aqueous fluid and forms into a liquid crystal in the presence of aqueous fluid. Also, a pharmaceutical composition further comprising a pharmacologically active ingredient plus the pre-concentrate is provided.
摘要翻译：公开了一种缓释脂质预浓缩物，其包含：a）具有至少两个或更多个-OH（羟基）基团的极性头的脱水山梨糖醇不饱和脂肪酸酯; b）磷脂; 和c）不含可离子化基团的具有15至40个碳原子的疏水部分的具有三酰基或碳环结构的液晶硬化剂。脂质预浓缩物在没有水性流体的情况下以液相形式存在，并在含水流体存在下形成液晶。此外，还提供了还包含药理活性成分加上预浓缩物的药物组合物。

15. 发明授权

US08121152B2 Method for encoding broadcast channel protocol data unit based on broadcast control channel scheduling error in universal mobile telecommunications system 有权
标题翻译：基于通用移动电信系统中的广播控制信道调度误差对广播信道协议数据单元进行编码的方法
公开(公告)号：US08121152B2
公开(公告)日：2012-02-21
申请号：US11828105
申请日：2007-07-25
申请人： Yunhee Cho , Ji Yeon Kim , Gweon Do Jo , Jin Up Kim
发明人： Yunhee Cho , Ji Yeon Kim , Gweon Do Jo , Jin Up Kim
IPC分类号： H04J3/00
CPC分类号： H04W48/12
摘要： A method for encoding a broadcast channel protocol data unit (BCH PDU) based on a broadcast control channel (BCCH) scheduling error in a universal mobile telecommunications system (UMTS) having a Node B and a radio network controller includes setting up a call between the radio network controller and the Node B to receive system information and scheduling information for a system information update from the radio network controller; initializing broadcast channel protocol data units and control information for every system frame number (SFN) at the Node B; and detecting the broadcast control channel scheduling error on the scheduling information for the system information update based on segment types of the system information when combining the system information for every system frame number. In case the broadcast control channel scheduling error is not detected, the broadcast channel protocol data units are encoded to be incorporated therein the system information.
摘要翻译：在具有节点B和无线网络控制器的通用移动通信系统（UMTS）中，基于广播控制信道（BCCH）调度误差对广播信道协议数据单元（BCH PDU）进行编码的方法包括：无线电网络控制器和节点B从无线电网络控制器接收用于系统信息更新的系统信息和调度信息; 对节点B的每个系统帧号（SFN）初始化广播信道协议数据单元和控制信息; 以及当对于每个系统帧号组合系统信息时，基于系统信息的段类型来检测用于系统信息更新的调度信息的广播控制信道调度误差。在没有检测到广播控制信道调度错误的情况下，广播信道协议数据单元被编码为并入其中的系统信息。

16. 发明申请

US20100273467A1 METHOD FOR PROVIDING OF CALL TRANSFERRING SERVICE AND MOBILE TERMINAL USING THE SAME 审中-公开
标题翻译：用于提供呼叫转移服务和使用该呼叫终端的移动终端的方法
公开(公告)号：US20100273467A1
公开(公告)日：2010-10-28
申请号：US12747881
申请日：2008-07-29
申请人： Hyung Jin Kim , Yun Hee Cho , Ji Yeon Kim , Seong Chul Cho , Gweon Do Jo , Jin Up Kim
发明人： Hyung Jin Kim , Yun Hee Cho , Ji Yeon Kim , Seong Chul Cho , Gweon Do Jo , Jin Up Kim
IPC分类号： H04W4/00
CPC分类号： H04M3/436 , H04M2203/2011
摘要： A method of providing a call transfer service and a mobile terminal using the same are provided. When a call connection request signal transmitted to a mobile communication server through a PSTN is received, any one of previously stored phone numbers is selected and a service of transferring a call to the selected phone number according to the received call connection request signal is requested. Therefore, when call connection is requested, it is selected whether a call is to be transferred, when a call is transferred, a phone number to transfer a call can be dynamically selected according to a user situation, and thus user convenience according to call transfer can be improved.
摘要翻译：提供一种提供呼叫转移服务的方法和使用其的移动终端。当接收到通过PSTN发送到移动通信服务器的呼叫连接请求信号时，选择先前存储的电话号码中的任一个，并且请求根据所接收的呼叫连接请求信号向所选择的电话号码传送呼叫的服务。因此，当请求呼叫连接时，选择是否传送呼叫，当呼叫转移时，可以根据用户情况动态地选择转接呼叫的电话号码，从而根据呼叫转移方便用户的方便可以改进。

17. 发明授权

US08626207B2 Method of checking modification of transmitted message in mobile communication terminal and mobile communication terminal performing the same 有权
标题翻译：在移动通信终端和执行该消息的移动通信终端中检查发送消息的修改的方法
公开(公告)号：US08626207B2
公开(公告)日：2014-01-07
申请号：US11856553
申请日：2007-09-17
申请人： Ji Yeon Kim
发明人： Ji Yeon Kim
IPC分类号： H04W4/00 , H04M1/725 , G06F15/16
CPC分类号： H04W4/12 , H04W4/18 , H04W88/184
摘要： A method of checking for modification of a message transmitted by a transmitting mobile terminal comprises transmitting an original message to a receiving mobile terminal, receiving a report message comprising information about any modification of the original message, and displaying information about the modification of the original message.
摘要翻译：一种检查由发送移动终端发送的消息的修改的方法包括：向接收移动终端发送原始消息，接收包括关于原始消息的任何修改的信息的报告消息，以及显示关于原始消息的修改的信息。

18. 发明申请

US20110223660A1 COMPOSITIONS FOR INDUCING DIFFERENTIATION INTO RETINAL CELLS FROM RETINAL PROGENITOR CELLS OR INDUCING PROLIFERATION OF RETINAL CELLS COMPRISING WNT SIGNALING PATHWAY ACTIVATORS 有权
标题翻译：用于诱导来自末端原核细胞的细胞分化或诱导包含WNT信号途径激活剂的细胞增殖的组合物
公开(公告)号：US20110223660A1
公开(公告)日：2011-09-15
申请号：US13055708
申请日：2010-10-06
申请人： Sung Sup Park , Ji Yeon Kim
发明人： Sung Sup Park , Ji Yeon Kim
IPC分类号： C12N5/071 , C12N5/07
CPC分类号： C12N5/062 , A61K35/12 , C12N2500/44 , C12N2501/105 , C12N2501/115 , C12N2501/155 , C12N2501/385 , C12N2501/41 , C12N2501/415 , C12N2506/02 , C12N2506/45
摘要： Disclosed is a composition for inducing the proliferation of retinal cells or the differentiation of retinal progenitor cells into retinal cells. The composition, similar to in vivo conditions for development during embryogenesis, induces stem cells to differentiate into a multitude of photoreceptor cells at high yield within a short period of time, without an additional gene transfer. In addition, the differentiated photoreceptor cells are useful in cellular therapy because they, when transplanted into degenerated or injured retinas, can be engrafted and fused within the retinas to prevent or cure retinal degeneration.
摘要翻译：公开了用于诱导视网膜细胞增殖或将视网膜祖细胞分化成视网膜细胞的组合物。与胚胎发生期间的体内发育条件类似的组合物诱导干细胞在短时间内以高产率分化成多种感光细胞细胞，而不需要额外的基因转移。此外，分化的感光细胞可用于细胞治疗，因为它们在移植到退化或损伤的视网膜中时可以被植入并融合在视网膜内以预防或治愈视网膜变性。

19. 发明申请

US20100086550A1 ANTICANCER AGENT COMPRISING ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY 审中-公开
标题翻译：包含抗PD-1抗体或抗PD-L1抗体的抗体试剂
公开(公告)号：US20100086550A1
公开(公告)日：2010-04-08
申请号：US12410732
申请日：2009-03-25
申请人： Chang Yuil Kang , Woo Sung Chang , Ji Yeon Kim
发明人： Chang Yuil Kang , Woo Sung Chang , Ji Yeon Kim
IPC分类号： A61K39/395
CPC分类号： C07K16/2818 , A61K39/39558 , A61K2039/505 , C07K16/2827 , C07K2317/76 , A61K2300/00
摘要： Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.
摘要翻译：提供一种抗癌剂，其包含抗PD-1抗体或抗-PD-L1抗体作为活性成分，其功能是通过用iNKT细胞配体施用而逆转已经诱导了无反应性的iNKT细胞的无反应性。抗PD-1或抗PD-L1抗体阻断PD-1 / PD-L1介导的信号通路，不仅可以防止iNKT细胞配体诱导的iNKT细胞无反应，而且可以逆转已经无能的iNKT的无反应性细胞产生细胞因子。此外，抗PD1或抗PD-L1抗体确保iNKT细胞的有效的抗肿瘤活性，如通过体内B16F10黑素瘤转移模型中转移性结节数量的显着减少所证实的。总的来说，抗癌剂在治疗癌症，特别是转移性癌症中是非常有用的。

20. 发明授权

US08617546B2 Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody 有权
标题翻译：包含抗PD-1抗体或抗-PD-L1抗体的抗癌剂
公开(公告)号：US08617546B2
公开(公告)日：2013-12-31
申请号：US13398915
申请日：2012-02-17
申请人： Chang Yuil Kang , Woo Sung Chang , Ji Yeon Kim , Dong-Hyeon Kim
发明人： Chang Yuil Kang , Woo Sung Chang , Ji Yeon Kim , Dong-Hyeon Kim
IPC分类号： A61K39/00
CPC分类号： C07K16/2818 , A61K39/39558 , A61K2039/505 , C07K16/2827 , C07K2317/76 , A61K2300/00
摘要： Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.
摘要翻译：提供一种抗癌剂，其包含抗PD-1抗体或抗-PD-L1抗体作为活性成分，其功能是通过用iNKT细胞配体施用而逆转已经诱导了无反应性的iNKT细胞的无反应性。抗PD-1或抗PD-L1抗体阻断PD-1 / PD-L1介导的信号通路，不仅可以防止iNKT细胞配体诱导的iNKT细胞无反应，而且可以逆转已经无能的iNKT的无反应性细胞产生细胞因子。此外，抗PD1或抗PD-L1抗体确保iNKT细胞的有效的抗肿瘤活性，如通过体内B16F10黑素瘤转移模型中转移性结节数量的显着减少所证实的。总的来说，抗癌剂在治疗癌症，特别是转移性癌症中是非常有用的。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式